The characteristics of the ZVCA roadshow project: the president unit recommends projects that have participated in the investment and are currently launching a new round of financing; or projects that currently have investment intentions. Through the "project roadshow + Q&A session” to president, and the  the association's large platform aims to build a bridge of cooperation for quality projects and investors. 

Supporting unit: Xing Roadshow

Sending Bio

Senlang Bio is a leading CAR-T cell therapy company in China. Ms. Guo Shengmin, the CEO of the company, has nearly 20 years of experience in the operation and management of large-scale pharmaceutical companies and has rich industry resources. Dr. Li Jianqiang, the chief scientist, was a senior scientist at the Fred Hutchinson Cancer Research Center in Seattle and has more than 10 years of work experience in the cancer immunity industry. More than 60 CAR-T cell transfusions have been completed and the overall response rate is close to 100%. Completed the first double CAR treatment in China. In the field of solid tumors, the company applied a unique patent portfolio CAR-T, a unique generic CAR-γδT, and stocked 16 different target CAR-T products. 

Vice President of ZVCA

Beijing Enterprises Medical and Health Industry Fund General Manager / Beijing Enterprises Medical and Health Industry Group Vice Chairman

Fengzhi HE

StarCombo

Approved by the Ministry of Health (TGA), StarCombo is manufacturer and brand owner of high-grade Australian cosmetics, health supplements and health supplements, including vitamins and skin care products. The business started in 2001 and was mainly focused on the sales of OEM and independent products. With the recent acquisition of a well-established brand, the group will be even more committed to adding new branded product lines.

A unique company combines manufacturing capabilities and a complete health product branding and distribution. Product distribution is sold to Australia via one of Australia's largest healthcare product groups.

Among the existing shareholders,there is a large Chinese medical group that provides strategic assistance for the company’s expansion plans in the Chinese market.

OneCorp

OneCorp is an Australian company that operates and develops biodegradable agricultural plastic membranes. The company focuses on providing field crop solutions for the purpose of increasing crop yields and solving “white pollution” caused by non-degradable plastic film. The product not only can achieve the purpose of environmental protection, but also can promote the increase of crop yield, and it is also more water-saving and more procurable.

The company has collaborated with CSIRO to validate the commercial use of its degradable plastic film products. In addition, more than 30 field experiments were conducted among local cotton farmers and corn farmers. The company has established business partnerships in Australia, China and the United States.

Corporate Vision: Clearing the Environmental Crisis from China's "White Pollution"

Corporate Mission: Significantly increase global economic crop yields and eliminate plastic pollution

Juda Guangdian

Yanzi Yimei

Yixin Tianxia

Longxi Media